QRXPY ($3.78) - Upcoming Advisory Committee 04.25.2014 - United States Food and Drug Administration (FDA) has set 22 April 2014 as the date of the Advisory Committee meeting to consider the Company’s resubmitted Moxduo New Drug Application (NDA).
QRXPY yeah I am holding. I am hoping to get out in the $4.30 range. There are two very strong catalyst with this one. I think one of these days we will see a very big green candle.